Colon News and Research

RSS

Cancers often recur after treatment with single drugs that “target” tumor cells’ genetic pathways

Targeted cancer cell therapies using man-made proteins dramatically shrink many tumors in the first few months of treatment, but new research from Johns Hopkins scientists finds why the cells all too often become resistant, the treatment stops working, and the disease returns.

14 Jun 2012

State roundup: N.Y.'s drug Rx bill passes unanimously, Mass. poll finds Dr. communication essential

New York lawmakers unanimously approved legislation Monday that will require doctors to issue drug prescriptions electronically within three years, meanwhile establishing tighter restrictions on painkillers and other addictive drugs on the state list of controlled substances.

13 Jun 2012

Study reveals mystery of how pancreatic cancer escapes immune detection

Researchers at NYU School of Medicine have made a key discovery that could help doctors treat one of the deadliest cancers.

12 Jun 2012

Study shows how infections provoke tissues into becoming cancerous

One of the biggest risk factors for liver, colon or stomach cancer is chronic inflammation of those organs, often caused by viral or bacterial infections. A new study from MIT offers the most comprehensive look yet at how such infections provoke tissues into becoming cancerous.

12 Jun 2012

ColoPrint aids prediction of colorectal cancer relapse

A novel microarray-based 18-gene expression tool known as ColoPrint significantly improves prognostic accuracy in stage II colon cancer patients who have undergone surgery, suggest study findings.

11 Jun 2012

Vitamin D deficiency may account for unexplained disparities in cancer survival rates

A paper just published in Dermato-Endocrinology suggests that vitamin D deficiency may account for unexplained disparities in cancer survival rates between African and White Americans.

10 Jun 2012

Study reviews role of gut microbes in nutrient absorption and energy regulation

Microorganisms in the human gastrointestinal tract form an intricate, living fabric made up of some 500 to 1000 distinct bacterial species, (in addition to other microbes). Recently, researchers have begun to untangle the subtle role these diverse life forms play in maintaining health and regulating weight.

7 Jun 2012

New evidence to support a range of healthy behaviors

Five new studies provide evidence to support simple steps we can take to prevent illness and improve our overall health. In the June issue of The American Journal of Medicine, researchers report on fish consumption to reduce the risk of colon cancer; the effectiveness ofhypnotherapy and acupuncture for smoking cessation; regular teeth cleaning to improve cardiovascular health; the effectiveness of primary care physicians in weight loss programs; and the use of low-dose aspirin to reduce cancer risk.

5 Jun 2012

New evidence of important role of next-generation sequencing in cancer treatment

Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer genomic analysis to routine clinical care, today announced results from two studies using next-generation sequencing (NGS) to provide actionable information about genomic tumor alterations in individual patients' cancers across all solid tumor types.

2 Jun 2012

Study supports wider testing for immune-based therapies to treat advanced non-small cell lung cancer

Two clinical trials led by Johns Hopkins Kimmel Cancer Center researchers in collaboration with other medical centers, testing experimental drugs aimed at restoring the immune system's ability to spot and attack cancer, have shown promising early results in patients with advanced non-small cell lung cancer, melanoma, and kidney cancer.

2 Jun 2012

Agendia launches ColoPrint microarray-based 18-gene expression signature for colon cancer

Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, today announced the launch of its ColoPrint microarray-based 18-gene expression signature for predicting the risk of distant recurrence for stage II colon cancer patients who have undergone surgery.

2 Jun 2012

First U.S.-based study to assess per-patient annual economic costs of fecal incontinence

Care for patients with fecal incontinence costs $4,110 per person for both medical and non-medical costs like loss of productivity, according to new research from the University of Michigan.

2 Jun 2012

Personalized medicine and the Human Genome Project

It’s nearly a decade since the completion of the Human Genome Project, (1) which aimed to sequence the complete human genome.

1 Jun 2012

Ventana, leading cancer researchers partner to commercialize novel IHC primary antibody

Ventana Medical Systems, Inc., a member of the Roche Group, has signed an exclusive license agreement with the German Cancer Research Center and University Hospital Heidelberg, Germany to commercialize a novel immunohistochemistry (IHC) primary antibody developed by researchers Andreas von Deimling, MD, Hanswalter Zentgraf, PhD and David Capper, MD, to detect the V600E BRAF mutation protein.

1 Jun 2012

Covidien introduces Endo GIA Radial Reload with Tri-Staple technology for LAR procedures

Covidien, a leading global provider of healthcare products, today announced the launch of the Endo GIA Radial Reload with Tri-Staple technology.

1 Jun 2012

Insurers make patients pay hundreds more for cancer, arthritis drugs

Thousands of patients taking costly drugs for ailments such as cancer and rheumatoid arthritis are being asked to shoulder a greater share of the expense. In other news, consumers are demanding access to their medical device data. Others are harnessing the internet to jumpstart medical research and share important experiences, including serious illnesses, with family and friends.

30 May 2012

Researchers develop tentative model for diagnosis of colon cancer

Researchers from the Universidad Politécnica de Madrid's Facultad de Informática, the Universidad del País Vasco, the Gaiker Technology Centre (Biscay) and the Hospital de Cruces in Barakaldo, have developed a tentative model for the diagnosis of colon cancer based on a biomarker panel.

28 May 2012

Viewpoints: Bill could make universal health care possible via states; The need to change how physicians are paid

Universal coverage, Medicare for all, single payer -- call it what you will. It's clear that conservative forces are determined to prevent such a system from ever being introduced at the national level. So it's up to the states.

25 May 2012

Flexible sigmoidoscopy reduces deaths due to colorectal cancer

Research conducted at the University of Alabama at Birmingham as part of a national study reveals that flexible sigmoidoscopy — a screening test for colorectal cancer that is less invasive and has fewer side-effects than colonoscopy — reduces deaths due to colorectal cancer.

23 May 2012

Prodigy Generics launches injectable irinotecan

Prodigy Generics, a division of Prodigy Health Supplier Corporation (PHS), has launched injectable irinotecan. Irinotecan is the generic equivalent of the branded drug Camptosar by Pfizer.

23 May 2012

Colon News and Research

Cancers often recur after treatment with single drugs that “target” tumor cells’ genetic pathways

State roundup: N.Y.'s drug Rx bill passes unanimously, Mass. poll finds Dr. communication essential

Study reveals mystery of how pancreatic cancer escapes immune detection

Study shows how infections provoke tissues into becoming cancerous

ColoPrint aids prediction of colorectal cancer relapse

Vitamin D deficiency may account for unexplained disparities in cancer survival rates

Study reviews role of gut microbes in nutrient absorption and energy regulation

New evidence to support a range of healthy behaviors

New evidence of important role of next-generation sequencing in cancer treatment

Study supports wider testing for immune-based therapies to treat advanced non-small cell lung cancer

Agendia launches ColoPrint microarray-based 18-gene expression signature for colon cancer

First U.S.-based study to assess per-patient annual economic costs of fecal incontinence

Personalized medicine and the Human Genome Project

Ventana, leading cancer researchers partner to commercialize novel IHC primary antibody

Covidien introduces Endo GIA Radial Reload with Tri-Staple technology for LAR procedures

Insurers make patients pay hundreds more for cancer, arthritis drugs

Researchers develop tentative model for diagnosis of colon cancer

Viewpoints: Bill could make universal health care possible via states; The need to change how physicians are paid

Flexible sigmoidoscopy reduces deaths due to colorectal cancer

Prodigy Generics launches injectable irinotecan

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News